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1. Introduction 
1.1 Producing area 
Under the guidance of the theory of the Traditional Chinese Medicine, many plants, animals 
and minerals in China can be medicines to treat the human diseases. Synchronously, the 
capacious land, sea and rich mineral deposits supply resources for them. Before they 
become medicines, they need grow and be gathered in some areas. But in these areas the 
weather, geographic features and biologic distributions are very different such as the 
different natural zones. Therefore these comprehensive factors endow Chinese medicines 
with different biological features and effects. After long time use, the medical practitioners 
gradually found the quantity or quality of some Chinese medicines which were produced in 
different areas were also different. An appellation came into being, which was called famous 
region drug.  
1.2 Famous region drug 
This appellation means those medicines which have good breeds and higher quality grow in 
some characteristic regions and feasible growing environments. They are cultivated and 
processed reasonably and output is great.    
One thousand and five hundred years ago, in (Annotated Shen Nong's Herbal), Jinghong 
Tao had discussed the producing areas of Chinese Medicine. But at Yuan dynasty, famous 
region drug were first written in (Peony Pavilion) Xianzu Tang wrote. Until Tang dynasty, 
the government divided the country into ten areas according natural form. So Simiao Sun 
recorded famous region drugs producing in these areas in(a supplement to the essential 
prescriptions worth a thousand gold). (commentaries on the illustrations)written by Song Su 
and (Compendium of Materia Medica)written by Shizhen Li both recorded the regions and 
quality of Chinese Medicine. Now some places in China are famous regions of Chinese 
Medicines, such as Sichuan province, Guangdong province, Shandong province where 
respectively produced Rhizoma Chuanxiong, Fructus Amomi, Equus asinus L.  
1.3 Magnolia officinalis 
Magnolia officinalis are from the barks of Magnolia officinalis Reha. et Wils. and Magnolia 
officinalis Reha. et Wils.var. biloba. Reha. et Wils which belong to Magnoliaceae [1]. Its 
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producing areas mainly include Sichuan, Hubei and Jiangxi province [2]. The characters of 
its medicinal materials usually showed single or double drum, grey outer surface with 
vertical wrinkles, purple brown inter surface with wiped oil mark and section with fine 
crystallization. Microstructure of its medicinal materials usually showed stone and oil cells 
or starch grains. The modern research also showed that its main effective component is 
magnolol and honokiol. 
 
 
Fig. 1. Medicinal plant of Magnolia officinalis 
 
 
Fig. 2. Medicinal materials of Magnolia officinalis 
It is wide used in clinic due to the effect of eliminating dampness and phlegm, promoting qi 
and removing distention. But the resource of Magnolia officinalis is decreasing and the 
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imbalance between supply and demand is outstanding in recent years. It has been involved 
in natural protected Chinese medicine. Its variety research seems very urgent for looking for 
its substitute.  
2. Purpose 
To explore the exact substitute and the quality evaluation, optimization methods of 
Magnolia officinalis, the comprehensive varieties researches based on its adulterants and 
substitutes and quality evaluation methods were reviewed.  
3. Methods 
The appearance characters, microstructure, physical and chemical(including Thin-Layer 
Chromatography and high performance liquid chromatography) and randomly amplified 
polymorphic DNA(RAPD) identification, 1H Nuclear magnetic resonance spectroscopy, 
powder X-ray diffraction fourier fingerprint, polyamide chromatography of different 
adulterants and substitutes were applied according to the records. And they were reviewed. 
The results showed that they totally contained ten families and forty - three varieties. The 
influence factors on the quality of Magnolia officinalis and the other quality evaluation 
methods were also reviewed.  
4. Result and conclusion 
4.1 Families and varieties of plants identified with Magnolia officinalis and identified 
methods 
The difference between Magnolia officinalis and these adulterants and substitutes were 
significant through the research. Firstly the morphological and(or) histological characters of 
some varieties were different from Magnolia officinalis, such as sikimmi, aleurites montana, 
Magnolia rostrata w w smith, Manglietia szechuanica Hu., Neolitsea levinei Merr., 
phyllanthi fructus, White yulan Magnolia, bigleaf magnolia bark, Wudang yulan magnolia, 
Magnolia wilsonii, camphortree bark , M.szechuanica Hu, M.insignis(Wal1.)Bl, Manglietia 
chingii Dandy, Manglietia yuyuanensis Law, sprenger magnolia bark, sargent magnolia 
bark, Magnolia wilsonii , Magnolia campbellii Hook.f.et Thoms., Mountain yulan Magnolia, 
M.szechuanica Hu, Manglietia chingii Dandy [3-14]. Secondly some physical and chemical 
identification showed significant results between Magnolia officinalis, Wudang magnolia 
bark, Magnolia campbellii Hook.f.et Thoms., albiziae , thinleaf machilus and Ormosia 
balansae. [15-17].The thin-Layer Chromatography analyzing also showed Magnolia 
officinalis were very different from the following adulterants and substitutes: (1)Wudang 
magnolia bark, Xikang magnolia bark and sargent magnolia bark were identified with 
cyclohexane-chloroform-ethanol (7:3:1) as developer and 5% vanillin sulfuric acid solution 
as coloration using silica gel G and observed at 254 nm using ultraviolet lamp [18]. (2)White 
yulan Magnolia, biond magnolia flower, shikimmi, red nanmu, aleurites montana, schima 
root-bark, Albizziakal Kora(Roxb).Prain., arbutus were identified with benzene-methanol 
(27:1) as developer and vanillin sulfuric acid solution as coloration using silica gel G and 
observed at 365 nm using ultraviolet lamp [19]. (3)Magnolia campbellii Hook.f.et 
Thoms.was identified with benzene-methanol (9:1) as developer and 1% vanillin sulfuric 
acid solution as coloration using silica gel G [20]. (4) Guangxi Manglietia was identified with 
benzene-methanol (8:2) as developer and 5% vanillin sulfuric acid solution as coloration  
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Table 1. Families and varieties of plants identified with Magnolia officinalis 
using silica gel G [21]. (5) Juglans mandshurica Maxim.,Wild walnut, Paulownia tomentosa 
(Thunb.) Steud.and Mountain yulanMagnolia were identified with benzene-methanol (27:1) 
as developer and 1% vanillin sulfuric acid solution as coloration using silica gel G [22-25]. 
(6) Tianmu mountain magnolia immature flower was identified with benzene-ethyl acetate-
methanol (27:1) as developer using silica gel G [26]. (7)Mt. Huang magnolia bar k, 
Manglietia yuyuanensis Law, Michelia maudiae were identified with benzene-methanol 
(27:1) as developer and 5% vanillin sulfuric acid solution as coloration using silica gel G [27]. 
(8) Qinshi Manglietia was identified with chloroform-methanol as developer and 5% 
vanillin sulfuric acid solution as coloration using silica gel G [28]. (9)Engelhardia 
roxburghiana Wal1 was identified with benzene-methanol (9:1) as developer and 1% 
vanillin sulfuric acid solution as coloration using silica gel G [29]. High performance liquid 
chromatography(HPLC) detection showed the total amount of magnolol and honokiol in 
Magnolia wilsonii, sprenger magnolia bark, and sargent magnolia bark were corresponding 
with PRC codex 2005 which was on Permaphase ODS, under the condition of mobile phase 
of benzene:phosphate(70:30) with the flow rate of 1.0ml/min. The calibration curves showed 
linear regression r > 0.9989. The recoveries ranged from 99.04% to 105.45%. [30]. But there 
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was no magnolol and honokiol in white yulan Magnolia, purple yulan Magnolia, magnolia 
bioudii and Wudang yulan magnolia on Permaphase ODS，under the condition of mobile 
phase of benzene:water (74.5:25.5) with the flow rate of 1.0ml/min. Most of manglietia and 
Mountain yulan Magnolia contain small amounts of magnolol and honokiol [31]. The 
randomly amplified polymorphic DNA was also used to identify the certified products and 
the adulterants and substitutes of Magnolia officinalis like yulan magnolia, magnolia 
bioudii, Wudang yulan magnolia, purple  yulan Magnolia, Mountain yulan Magnolia, 
Manglietia chingii Dandy, M.insignis(Wal1.)Bl and liriodendron.The result showed that the 
DNA Fingerprinting of Magnolia officinalis was very different from that of these 
adulterants and substitutes [32]. 15 samples of cortex Magnolia officinalis from different 
origin, 1 standard sample of Magnolia officinalis and 1 Wudang yulan magnolia were 
identified by 1H Nuclear magnetic resonance spectroscopy. The fingerprint showed that 1H-
NMR could be an accurate and feasible method for the quality control of Magnolia 
officinalis [33]. Powder X-ray diffraction fourier fingerprint pattern was developed to 
identify and analyze Magnolia officinalis. Experiments and analysis were carried out on 3 
samples of cortex Magnoliae officinals, 3 samples of cortex Magnolia bilobae, 14 samples of 
substitute and one counterfeit of cortex Magnolia officinals. It was found that this method 
can be used for identification on Chinese medicinal material Cortex Magnolia officinals 
[34].The characteristic chromatogram for cortex Magnolia officinalis was established by 
using polyamide chromatography (PC) to identify the cortex Magnolia officinalis from 
different origin and its substitute and false products. The result showed that this method 
could be used for the identification and quality evaluation for cortex Magnolia officinalis 
[35].  
4.2 Influence factors and determinative methods of quality of Magnolia officinalis 
The content of magnolol and honokiol of Magnolia officinalis collected from 7 provinces, 11 
counties and Jingning provenance testing forest of Zhejiang province were detected as 
quality standards by using HPLC. And the correlation analysis between the factors which 
would affect the quality of Magnolia officinalis and the content of magnolol and honokiol 
was applied. The result showed that many factors would affect the quality of Magnolia 
officinalis significantly, such as provenance, producing area, blade profile, DBH, tree height, 
crown width, tree age, bar thickness, powder color, oiliness, grindability, bark type and 
position of sampling, etc. Among them, provenance, blade profile, powder color, bark 
thickness, DBH and position of sampling were more significant factors, especially the 
variety [36]. However some other researches showed tree age and length of storage period 
would be two factors which affected the quality of Magnolia officinalis [37-38]. After 
analysis, geographical position and Climate, blade profile and variety firstly maybe would 
affect the quality of Magnolia officinalis, especially the provenances with a sharpened leaf 
tip from Hubei Province has a highest content of phenols, and that with a concave leaf tip 
from the Lushan Mountain has a lowest content of phenols [39-40]. Secondly, there was 
positive correlation between the growth factors of Magnolia officinalis including tree age, 
DBH, tree height, crown width and content of phenols of Magnolia officinalis, especially the 
DBH [41]. Thirdly, appearance characters including bark thickness, powder color, 
grindability and bark roughness were regarded as the main traditional basis for the quality 
evaluation of Magnolia officinalis, which accorded with the research [42]. Position of 
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sampling was also a basis for the quality evaluation of Magnolia officinalis which included 
dry hide, root bark, shoot cortex, etc. Content of phenols of root bark from Magnolia 
officinalis was 3-5 times higher than that of shoot cortex from Magnolia officinalis [41]. 
Besides the TLC and HPLC, amplified fragment length polymorphism analysis was applied 
as a method for further study with molecular markers in the field of genetic diversity, for 
breeding new cultivars, and for genetic relationships with Magnolia officinalis [43]. First 
derivative of UV spectrophotometry was also used to analyze compositions of Magnolia 
officinalis. The result showed that this method could eliminate interference of other 
impurity and make all samples exhibit maximum absorbance at 300nm [44]. A gas 
chromatography/mass spectrography was developed to identify the compositions of 
Magnolia officinalis, including magnolol, honokiol, δ-selinene and β-eudeomol, etc. And the 
content of magnolol and honokiol were determined [45]. The second order derivative 
synchronous fluorescence spectra of magnolol, honokiol and their mixture in 0.08%-0.16% 
methanol solution were studied. The experiment results indicated that their second order 
derivative synchronous fluorescence spectra were separated absolutely, which eliminated 
the disturbance between them [46]. To detect the contents of six trace elements ( Fe ,Cu ,Zn 
,Mn ,Ca ,Mg) in cortex Magnolia officinalis by flame atomic absorption spectroscopy, the 
contents of six trace elements ( Fe ,Cu ,Zn , Mn ,Ca and Mg) were determined by calibration 
curve method. The result showed that the Cortex Magnolia officinalis is rich in trace 
elements which are necessary for people [47]. Quantitative Measurement of magnolol and 
honokiol was tested by using excitation–emission Matrix Fluorescence coupled with 
second–order calibration algorithm. It showed that the second-order calibration methods 
could quantify the analysis of interest from overlapped chromatographic profiles and give 
the accurate predicted results by utilizing mathematical-separation instead of physics-
separation [48]. Fluorescent determination of magnolol has been effected employing the 
sensitivity- and stability-enhancing action of the non-ionic surface active emulsifier OP. As a 
result, the accuracy of determination was raised by 2 orders of magnitude as compared to 
that of ultraviolet spectrophotometry [49]. A highly sensitive and selective method was 
developed for the determination of honokiol and magnolol by HPLC-electrochemical 
detection, using a microbore column. The result showed that this method could be proposed 
for the determination of honokiol and magnolol in traditional Chinese medicines and 
human plasma sample [50]. 
All above-mentioned researches showed there were four kinds of factors mainly affecting 
the quality of Magnolia officinalis. And many methods had been used to determinate the 
content or compositions of Magnolia officinalis for the identification or quality control. 
Making and following the comprehensive and well-considered plans to develop famous 
region drugs would benefit protecting the environment, rare Chinese Medicine and 
highlighting characteristic of Chinese Medicines significantly.      
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